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Introduction
In eukaryotic cells, protein-encoding transcripts contain intronic 
sequences that must be spliced out before translation. This crucial 
step in gene expression is catalyzed by the spliceosome, a multi-
component RNP complex which consists of five major U1, U2, 
U4, U5, and U6 small nuclear RNP particles (snRNPs) in addi-
tion to other proteins (for reviews see Will and Lührmann, 2001; 
Jurica and Moore, 2003; Wahl et al., 2009). Each snRNP con-
sists of a unique small nuclear RNA (snRNA) associated with a 
specific set of proteins and a ring of seven Sm or Lsm proteins 
(Urlaub et al., 2001). During splicing, the spliceosome has to 
accomplish several functions that involve correct intron recogni-
tion, a two-step transesterification reaction to cleave out introns 
and join together exons, and finally the release of mature mRNA 
(for reviews see Staley and Guthrie, 1998; Wahl et al., 2009).
Although the process of spliceosome assembly has been 
intensively studied, the precise mechanism of its in vivo forma-
tion is still not fully understood. Two models of spliceosome as-
sembly during precursor mRNA (pre-mRNA) splicing have been 
proposed: (1) the step-wise assembly model, which proposes   
sequential assembly of individual snRNPs on pre-mRNA, and 
(2) the penta-snRNP or supraspliceosome model, which predicts 
that a preformed spliceosome containing all snRNPs is recruited 
to pre-mRNA (for review see Rino and Carmo-Fonseca, 2009).
According to the step-wise model, snRNPs sequentially 
interact with the pre-mRNA transcript. Initially, intron boundar-
ies are recognized when the U1 snRNP interacts with the 5 splice 
site, and the U2 snRNP and associated factors interact with the 
branch point. Once the intron is defined, U4, U5, and U6 snRNPs 
are recruited as a preassembled U4/U6•U5 tri-snRNP. The splice-
osome then undergoes extensive conformational and compo-
sitional rearrangements that result in the release of U1 and   
U4 snRNA, together with their corresponding U1 and U4/U6   
snRNP–specific proteins, and the formation of the catalytic core 
that is essential for the transesterification reactions. When splicing 
is accomplished, mature mRNA is released, and the U2, U5, and 
U6 snRNPs dissociate from the intron lariat to be recycled for 
subsequent rounds of splicing. This model is based on numerous   
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catalyzed by the spliceosome, a large ribonucleo-
protein (RNP) complex composed of five small nuclear 
RNP particles (snRNPs) and additional proteins. Using live 
cell imaging of GFP-tagged snRNP components expressed 
at endogenous levels, we examined how the spliceosome 
assembles in vivo. A comprehensive analysis of snRNP 
dynamics in the cell nucleus enabled us to determine 
snRNP diffusion throughout the nucleoplasm as well as 
the interaction rates of individual snRNPs with pre-mRNA. 
Core components of the spliceosome, U2 and U5 snRNPs, 
associated with pre-mRNA for 15–30 s, indicating that   
splicing is accomplished within this time period. Additionally, 
binding of U1 and U4/U6 snRNPs with pre-mRNA oc-
curred within seconds, indicating that the interaction of 
individual snRNPs with pre-mRNA is distinct. These results 
are consistent with the predictions of the step-wise model 
of spliceosome assembly and provide an estimate on the 
rate of splicing in human cells.
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was isolated and shown to catalyze RNA splicing (Azubel et al., 
2006; Sperling et al., 2008). However, it was also reported in a 
human in vitro system that the penta-snRNP is not essential for 
early spliceosome assembly steps (Behzadnia et al., 2006). Fluores-
cence resonance energy transfer studies performed in live cells 
showed that the interaction between several splicing factors per-
sisted after transcriptional inhibition, indicating that the larger 
splicing complexes are formed in vivo in the absence of pre-mRNA 
(Chusainow et al., 2005; Ellis et al., 2008; Rino et al., 2008).
To elucidate the dynamic properties of snRNPs and their 
interactions with pre-mRNA in vivo, we used fluorescence cor-
relation spectroscopy (FCS) and FRAP. Live cell imaging tech-
niques have previously been used to investigate the dynamic 
properties of several macromolecular complexes, including splic-
ing factors and RNA polymerases (Dundr et al., 2002; Darzacq 
et al., 2007; Rino et al., 2007; Gorski et al., 2008) as well as the 
assembly of the exon junction complex (Schmidt et al., 2009). 
We took advantage of stable cell lines that contained integrated 
bacterial artificial chromosomes (BACs) that encoded recombi-
nant GFP-tagged snRNP proteins expressed under endogenous 
regulatory elements. Thus, the expression of GFP-tagged snRNP 
proteins mimics the expression of their endogenous counterparts 
(Poser et al., 2008; Sapra et al., 2009). Analysis of the dynamic 
behavior of snRNP-specific proteins in the cell nucleus revealed 
in vitro observations that demonstrated the sequential associa-
tion of individual snRNPs with pre-mRNA (Reed, 2000). Further-
more, in both yeast and mammalian in vitro systems, distinct 
intermediates of spliceosome assembly were detected and char-
acterized (Brody and Abelson, 1985; Konarska and Sharp, 1986; 
Bindereif and Green, 1987; Jurica et al., 2002; for review see 
Jurica and Moore, 2003). Finally, in yeast cells, chromatin immuno-
precipitation (ChIP) data showed the sequential association of 
snRNPs with nascent transcripts (Kotovic et al., 2003; Görnemann 
et al., 2005; Lacadie and Rosbash, 2005; Tardiff and Rosbash, 
2006; Tardiff et al., 2006). However, in mammalian cells, ChIP 
lacks the necessary resolution to analyze the dynamic aspects of 
spliceosome assembly (Listerman et al., 2006).
The second model proposes the existence of a preassembled 
spliceosome that is splicing competent. Multiple studies performed 
in yeast and mammalian systems have demonstrated the as-
sociation of U1 and U2 snRNPs with U4/U6 and U4/U6•U5   
snRNPs in the absence of pre-mRNA (Konarska and Sharp, 1988;   
Wassarman and Steitz, 1992). This alternative view was supported 
when the 45S complex was isolated from a yeast extract and 
was found to contain all five snRNPs. Subsequently, this com-
plex was referred to as the penta-snRNP (Stevens et al., 2002). 
Additionally, in human cells, a large 200S RNP particle named the 
supraspliceosome that contained four penta-snRNP–like subunits 
Figure 1.  GFP-tagged snRNP proteins incorporate into snRNPs. (A) Images of cells expressing GFP-tagged snRNP proteins. GFP-tagged proteins were 
localized to the nucleoplasm and enriched in splicing factor compartments and Cajal bodies (arrows). Bar, 5 µm. (B) snRNPs were immunoprecipitated   
using anti-GFP or anti-Sm antibodies, and coprecipitated RNAs were visualized. The positions of snRNAs and rRNAs are depicted. Note that a small 
amount of U6 and U5 snRNAs coprecipitate with U2 snRNP (U2A line) and U2 snRNA associated with U5 snRNP (hPrp8 and Snu114 lines). Vertical 
black lines indicate that intervening lanes have been spliced out. (C) Proliferation of control cells (hPrp31-GFP) and cells expressing mouse Snu114-GFP 
was assayed by DDAO staining after knockdown of endogenous hSnu114. Reduction of hSnu114 levels (see Western blot [WB]) resulted in proliferation 
defects that were partially rescued by expression of RNAi-resistant mouse Snu114-GFP. NC, negative control.77 Spliceosome assembly in the cell nucleus • Huranová et al.
splicing (Görnemann et al., 2005; Sapra et al., 2009). GFP-tagged 
snRNP proteins were properly localized to the cell nucleus and 
accumulated in Cajal bodies (Fig. 1 A). Immunoprecipitation 
followed by snRNA analysis revealed that the GFP-tagged pro-
teins were properly incorporated into the appropriate snRNPs 
(Fig. 1 B). In addition, knockdown of endogenous Snu114 by 
RNAi reduced the proliferation rate of control hPrp31-GFP by 
20% in comparison with cells expressing RNAi-resistant mouse 
Snu114-GFP (Fig. 1 C). We concluded that the GFP-tagged   
snRNP proteins behaved analogously to their endogenous counter-
parts and were suitable for further investigation.
To analyze the movement of snRNPs in the cell nucleus, 
we first used FCS, a tool sensitive enough to detect rapid diffu-
sion and fast interactions (Kim et al., 2007). This technique focuses 
a laser beam on a spot of interest in the nucleoplasm and moni-
tors fluctuations in fluorescence intensity over time. The inten-
sity record is transformed into an autocorrelation function that 
assesses the diffusion correlation time of the detected molecules. 
FCS measurements were performed within the nucleoplasm and 
compared with the splicing factor compartments (also termed 
nuclear speckles; Fig. 2 A and Table I; Neugebauer, 2002; Lamond 
and Spector, 2003). By using the pure diffusion model (Eq. 1), 
the intricate details of spliceosomal complex formation. In addi-
tion, we were able to estimate the rate of splicing in living human 
cells by analyzing the interaction between the core splice- 
  osomal snRNPs with pre-mRNA.
Results
FCS reveals the diffusion properties of the 
snRNP mobile fraction
To describe the dynamic behavior of snRNPs in living cells, we 
established stable HeLa cell lines that express from BACs the 
GFP-tagged snRNP proteins U2A (U2 snRNP), hPrp31 and 
hPrp4 (U4/U6 snRNP), and Snu114 (U5 snRNP). Previously 
used HeLa cell lines expressing BAC-encoded GFP-tagged   
snRNP proteins, U1-70K (U1 snRNP) and hPrp8 (U5 snRNP), were 
also used (Sapra et al., 2009). The advantage of using BACs for 
gene expression experiments is that the endogenous regulatory 
elements are preserved, allowing their expression to be similar 
to that of the endogenous protein. The expression of GFP-tagged 
snRNP proteins did not impair cotranscriptional spliceosome 
formation, and haploid yeast cells that express only GFP-tagged 
snRNP proteins remained viable without any defects in pre-mRNA 
Figure 2.  FCS measures the in vivo mobility of snRNPs. (A) FCS measurements were performed in the nucleoplasm of cells either stably expressing   
U1-70K–GFP or transiently expressing GFP. The autocorrelation function of free GFP is fitted with a one-component anomalous diffusion model. The auto-
correlation function of U1-70K is fitted with a two-component diffusion model. (B) The autocorrelation function of U1-70K1–197 is fitted with a two-component 
diffusion model. Deletion of the RNA-binding domain of U1-70K results in a fourfold increase in diffusion of the slow component. (C) DRB treatment (5 h) 
inhibits RNA polymerase II and results in the enlargement and rounding up of splicing factor compartments. DRB treatment had only a minimal effect on   
snRNP diffusion, with both fast and slow components still present. (A–C) Crosses indicate spots in the nucleoplasm where FCS measurements were performed, and 
weighted residuals are shown to assess the fit quality. Bar, 5 µm.JCB • VOLUME 191 • NUMBER 1 • 2010   78
pre-mRNA. We predict that these interactions occur over a longer 
time scale (seconds and more) beyond the detection limit of FCS.
snRNP diffusion measured by FRAP 
correlates with FCS data
To overcome the limits of FCS, we used FRAP to elucidate the 
relatively slow interaction of snRNPs with pre-mRNA. The FRAP 
method involves photobleaching of a small area within the sample 
and monitoring the recovery of fluorescence intensity over time. 
Fluorescence recovery reflects the movement of unbleached   
molecules into the bleached area and is determined by the diffu-
sion and binding characteristics of the analyzed molecules 
(Sprague et al., 2004; Sprague and McNally, 2005; McNally, 
2008). Importantly, pre-mRNA splicing is largely cotranscriptional   
(Neugebauer, 2002) and is significantly faster compared with RNA 
polymerase II elongation (Singh and Padgett, 2009). With respect 
to mobile snRNPs, pre-mRNA represents an immobilized sub-
strate. To dissect diffusion from binding events, we compared the 
dynamics of snRNPs in the nucleoplasm before and after tran-
scriptional inhibition (Fig. 3, A–D). FRAP measurements in 
DRB-treated  cells  showed  fast  and  full  fluorescence  recovery 
(Fig. 3, B–D), indicating that transcriptional inhibition depleted 
pre-mRNA–binding sites. Recovery curves were fitted with the 
pure diffusion model (Eq. 2), supporting the assumption that in 
the absence of pre-mRNA, snRNPs move rapidly throughout the 
nucleoplasm. Quantification of FRAP curves yielded effective 
diffusion coefficients ranging from 0.2 to 0.6 µm
2s
1 (Table II), 
which were comparable with the diffusion coefficient range of 
0.5–0.9 µm
2s
1 obtained by FCS (Table I). As the diffusion co-
efficients are lower than diffusion coefficients of freely diffusing 
macromolecular complexes of snRNP size (1 MD), these data 
indicate that in DRB-treated cells, both FRAP and FCS measured 
the effective diffusion, which is a combination of relatively low 
affinity binding events and free diffusion.
Increased mobility of snRNPs in the splicing factor compart-
ments after transcriptional inhibition indicated that snRNPs inter-
act with pre-mRNA in these compartments, as suggested previously 
(Rino et al., 2007). Although DRB treatment resulted in com-
plete fluorescence recovery in the nucleoplasm, we detected 10% 
a satisfactory fit of autocorrelation function was achieved (Kim   
et al., 2007). We detected two moving components in the nucleo-
plasm of each cell line expressing GFP-tagged snRNP proteins, 
with diffusion correlation times of around 1 ms for the fast com-
ponent (Da, 40% of all moving proteins) and 20–30 ms for the 
slow component (Db, 60% of all moving proteins; Fig. 2 A 
and Table I). Two populations were detected in the splicing factor 
compartments as well, and both components exhibited reduced 
diffusion in contrast to the nucleoplasm (Table I).
The correlation times of the fast component were similar 
to free GFP and likely reflected free proteins (Fig. 2 A and Table I). 
To elucidate whether the slow component represented snRNP 
complexes, we constructed a truncated form of the U1-70K protein 
lacking the first 1–197 aa that contain the U1 snRNA–binding 
motif (Nelissen et al., 1994). In agreement with previous results 
that demonstrated that the C-terminal domain is still able to inter-
act with non-snRNP proteins (Cao and Garcia-Blanco, 1998), 
we observed that the transiently expressed U1-70K1–197–GFP 
protein partially accumulated in splicing factor compartments 
(Fig. 2 B) but did not incorporate into the U1 snRNP (Fig. S1 A). 
FCS measurements revealed that deletion of the RNA-binding 
motif did not affect diffusion of the fast component but resulted 
in a dramatic decrease of the delay time of the slow component 
pointing to approximately fourfold faster movement of complexes 
containing the truncated protein (Fig. 2 B and Table I). We con-
clude that FCS measurements of wild-type snRNP proteins reveal 
the diffusion properties of snRNP complexes.
To examine whether the snRNP movement in the nucleo-
plasm is affected by its interaction with pre-mRNA, we treated 
cells with 5,6-dichlorobenzimidazole riboside (DRB), a potent 
inhibitor of RNA polymerase II (Chodosh et al., 1989). The treat-
ment resulted in an enlargement of splicing factor compartments 
(Fig. 2 C) and inhibited RNA synthesis (Fig. S2). FCS measure-
ments revealed that transcriptional inhibition had little effect on 
the diffusional behavior of snRNPs in the nucleoplasm (Fig. 2 C). 
In summary, using FCS, we showed that individual snRNPs dif-
fused rapidly throughout the nucleoplasm with comparable dif-
fusion correlation times (Table I). However, we were not able to 
detect any stable interactions between individual snRNPs and 
Table I.  Calculated parameters derived from FCS measurements
Proteins Nucleoplasm Splicing factor compartments
Da Dfa Db Dfb Da Dfa Db Dfb
ms µm
2s
1 ms µm
2s
1 ms µm
2s
1 ms µm
2s
1
U1-70K
a 0.56 ± 0.08 28.21 ± 4.22 24.92 ± 3.08 0.63 ± 0.08 0.67 ± 0.17 24.98 ± 7.41 33.68 ± 3.77 0.47 ± 0.05
U2A
a 0.67 ± 0.18 24.85 ± 6.87 19.91 ± 4.68 0.82 ± 0.20 0.72 ± 0.11 22.30 ± 3.70 26.82 ± 5.98 0.61 ± 0.15
hPrp31
a 0.99 ± 0.23 16.74 ± 5.40 18.08 ± 3.13 0.88 ± 0.15 0.97 ± 0.12 16.27 ± 2.01 20.55 ± 4.49 0.79 ± 0.18
hPrp4
a 0.76 ± 0.17 21.35 ± 4.49 24.68 ± 3.03 0.64 ± 0.08 1.06 ± 0.35 15.96 ± 4.54 22.46 ± 2.83 0.71 ± 0.10
hPrp8
a 0.64 ± 0.12 24.97 ± 4.50 30.29 ± 1.44 0.52 ± 0.02 0.78 ± 0.16 20.79 ± 4.34 33.83 ± 4.91 0.47 ± 0.07
Snu114
a 0.76 ± 0.24 22.09 ± 5.83 26.45 ± 5.16 0.61 ± 0.12 1.01 ± 0.09 15.58 ± 1.47 27.18 ± 2.78 0.58 ± 0.06
U1-70K1–197 0.58 ± 0.19 28.81 ± 6.36 6.80 ± 1.50 2.40 ± 0.55 0.82 ± 0.10 19.39 ± 6.36 6.18 ± 1.89 2.70 ± 0.66
EGFP 0.56 ± 0.05 27.87 ± 2.22 NA NA ND ND ND ND
NA, not applicable. Dynamics of snRNP proteins were measured in the nucleoplasm and the splicing factor compartments by FCS. The delay time values Da for EGFP 
are comparable with the values of the fast component detected in the FCS measurements of snRNP proteins. The values for the delay times Db describe the diffusion 
of the slow-moving component that reflects snRNP complexes. Da and Db were used to calculate the diffusion coefficients Dfa and Dfb, respectively. The mean ± SD 
from 8–10 cells is shown.
aBAC stable cell line.79 Spliceosome assembly in the cell nucleus • Huranová et al.
integrity. However, we noticed that the small amount of U6   
snRNAs that repeatedly copurified with U2 complexes in non-
treated cells was lost after transcriptional inhibition. In addition, 
after transcriptional inhibition, the levels of coprecipitated U4 
and U6 snRNAs with hPrp4 and hPrp8 proteins were reduced, 
illustrating that di- and tri-snRNP formation was impaired by 
this treatment.
snRNPs interact independently  
with pre-mRNA
To characterize the interaction of snRNPs with pre-mRNA in 
living cells, we analyzed nontreated cells by FRAP (Fig. 3, B–D). 
To apply a proper model for data fitting, we performed FRAP 
experiments with half of the nucleus bleached and analyzed   
fluorescence recovery at various distances from the bleached 
of immobile molecules in the splicing factor compartments. 
These results suggest the presence of snRNP-binding sites that 
are not dependent on transcription. In addition, after DRB treat-
ment, snRNPs diffused slower in the splicing factor compart-
ments than in the nucleoplasm, which correlated with FCS 
results. These data suggested an additional transient interaction 
not related to transcription and splicing that snRNPs encounter 
in the splicing factor compartments (Fig. S3 and Table II).
U4/U6 and U4/U6•U5 snRNP integrity 
depends on active transcription
To characterize the molecular composition of snRNP complexes 
after transcriptional inhibition, we immunoprecipitated snRNP-
specific proteins from DRB- or -amanitin–treated cells (Fig. 3 E). 
Transcriptional inhibition had no effect on U1 and U2 snRNP 
Figure 3.  snRNPs interact independently with pre-mRNA, as 
analyzed by FRAP. (A) FRAP measurements were performed in   
the nucleoplasm, as depicted by circles. Bar, 5 µm. (B–D) U1-70K   
(B), U2A (C), and hPrp8 (D) FRAP curves representing a 
mean of 10–15 measurements before and after DRB treatment 
are shown. FRAP curves were fitted either with a pure diffu-
sion model (DRB treatment) or the full model (no treatment). 
Calculated  diffusion  coefficients  and  dissociation  constants   
koff are shown in Table II. R
2 values evaluating fit quality 
are shown next to the curves. (E) Coimmunoprecipitation of   
snRNAs with anti-GFP antibodies from U1-70K-GFP, U2A-GFP, 
hPrp4-GFP, and hPrp8-GFP cell lines before and after DRB or 
-amanitin treatment. Transcriptional inhibition had no effect 
on the precipitation of U1 and U2 snRNAs but eliminated 
U6  snRNA  association  with  the  U2  snRNP.  Transcriptional 
inhibition reduced the formation of U4/U6 and U4/U6•U5 
snRNPs, as shown by the decrease of U4 and U6 snRNAs 
levels in hPrp4 (asterisks) and hPrp8 precipitates. NC, nega-
tive control. (F) Schematic representation of snRNP interaction 
times with pre-mRNA. We assume that the U4/U6 proteins 
hPrp4 and hPrp31 leave with the U4 snRNA, whereas U6 
snRNA stays associated with the activated spliceosome.JCB • VOLUME 191 • NUMBER 1 • 2010   80
To further show that koff values were indicative of snRNP 
binding to pre-mRNA, we performed FRAP measurements in cells 
treated with isoginkgetin, a potent splicing inhibitor. Isoginkgetin 
prevents U4/U6•U5 tri-snRNP recruitment to the spliceosome in 
vitro, resulting in the accumulation of prespliceosomal complex A 
that contains U1 and U2 snRNPs bound to pre-mRNA (Behzadnia 
et al., 2007; O’Brien et al., 2008). If koff represents the interaction 
of snRNPs with pre-mRNA, stabilization of complex A should de-
crease the koff value of the U1 snRNP. Splicing inhibition was con-
firmed by the enlargement of splicing factor compartments   
(Fig. 4 A; Kaida et al., 2007) and the accumulation of pre-mRNA 
from several genes (Fig. S5). Importantly, transcription was pre-
served, as measured by the incorporation of modified nucleotides 
(Fig. S2). Splicing inhibition resulted in the elevation of the U1 and 
U2 snRNP immobile fractions. Quantification of the mobile frac-
tion revealed the dramatic decrease in the U1 snRNP koff value (Fig. 4, 
B and F; and Table II). The in vivo formation of a stable U1–U2– 
pre-mRNA complex was further confirmed by the coimmuno-
precipitation of U1 snRNA with the U2A GFP-tagged protein from 
isoginkgetin-treated cells (Fig. 4 C). The prolonged residence time 
of the U1 snRNP on pre-mRNA complemented our measurements 
performed after transcriptional inhibition and demonstrated that 
the koff values signify snRNP interaction with pre-mRNA.
Splicing inhibition had a minor effect on the U4/U6   
di-snRNP protein dissociation rate and only slightly increased the 
amount of U4/U6 di-snRNP immobile fraction, suggesting its tran-
sient interaction with stalled spliceosomal complexes (Fig. 4,   
D and F; and Table II). U5 snRNP FRAP curves measured in 
isoginkgetin-treated cells showed rapid recovery, and their quan-
tification yielded diffusion coefficients that were comparable with 
the diffusion coefficients measured in DRB-treated cells (Fig. 4 E 
and Table II). Interestingly, we detected an apparent immobile frac-
tion of U5 snRNP that might indicate either stalled spliceosomal 
complexes containing U5 snRNP or interactions occurring before 
the first step of splicing (Wyatt et al., 1992).
area (Fig. S4). Distinct recovery profiles at different spots indi-
cated that diffusion significantly contributed to fluorescence re-
covery and could not be omitted. Thus, FRAP curves were fitted 
with the full model comprising both diffusion and binding   
parameters (Eq. 3; Sprague et al., 2004; McNally, 2008). To re-
duce the number of fitted parameters, we used diffusion coeffi-
cients measured by FCS and fitted only parameters that de-
scribed the binding event, association (k*on) and dissociation 
(koff) rates. Additionally, by fitting the FRAP data with the dif-
fusion coefficients measured after DRB treatment, similar koff 
values were calculated (unpublished data). Because k*on also 
depends on the concentration of binding sites, which could not 
be easily determined, only koff values were used to describe the 
interaction between snRNPs and pre-mRNA.
koff values calculated for the U1 snRNP and the U4/U6   
snRNP were >10-fold higher than koff for the U2 and U5 snRNPs, 
suggesting that U1 and U4/U6 snRNPs interact with pre-mRNA 
for a lesser time than U2 and U5 snRNPs (Table II). A sche-
matic representation of snRNP interactions with pre-mRNA is 
shown in Fig. 3 F, in which the interaction time was calculated 
as an inversion of koff. The longer association of U2 and U5   
snRNPs with pre-mRNA likely reflects the stable interaction of 
these two snRNPs with pre-mRNA during splicing and is indic-
ative of the in vivo splicing rate. Importantly, similar dissocia-
tion rates were obtained for different proteins from the same 
snRNP complex (hPrp8 and Snu114 from the U5 snRNP; hPrp4 
and hPrp31 from the U4/U6 snRNP), which suggests that these 
values accurately reflect the behavior of snRNP complexes   
(Table II). In addition, FRAP curves of U1-70K1–197–GFP 
protein did not indicate any stable interaction with pre-mRNA, 
and its fluorescence recovery was not affected by DRB treat-
ment (Fig. S1 B). Conclusively, in untreated cells, FRAP measure-
ments revealed that individual snRNPs have distinct dissociation 
rates,  strongly  indicating  that  snRNP  interactions  with  pre-
mRNA are independent.
Table II.  Calculated parameters derived from FRAP measurements in BAC HeLa and E3 U2-OS cell lines
Proteins Nucleoplasm Splicing factor compartments E3 gene loci
Df DRB koff nt koff isog Df isog Df DRB kofwnt koff E3 gene loci
µm
2s
1 s
1 s
1 µm
2s
1 µm
2s
1 s
1 s
1
U1-70K
a,b 0.27 ± 0.02 1.57 ± 0.21 0.058 ± 0.007 NA 0.33 ± 0.05 1.07 ± 0.26 NA
U2A
a,b 0.56 ± 0.05 0.062 ± 0.005 0.047 ± 0.006 NA 0.17 ± 0.02 0.050 ± 0.08 NA
hPrp31
a,b 0.55 ± 0.03 1.36 ± 0.30 0.63 ± 0.26 NA 0.24 ± 0.03 0.055 ± 0.005 NA
hPrp4
a,b 0.47 ± 0.08 1.55 ± 0.13 0.90 ± 0.23 NA 0.32 ± 0.04 0.048 ± 0.007 NA
hPrp8
a,b 0.27 ± 0.02 0.037 ± 0.004 NA 0.40 ± 0.02 0.10 ± 0.04 0.035 ± 0.005 NA
Snu114
a,b 0.26 ± 0.03 0.032 ± 0.006 NA 0.27 ± 0.03 0.19 ± 0.02 0.038 ± 0.007 NA
U1-70K
a,c 0.50 ± 0.05 1.88 ± 0.15 ND ND ND ND 0.112 ± 0.010
U2B
c 0.61 ± 0.07 0.064 ± 0.005 ND ND ND ND 0.056 ± 0.009
hPrp4
c 0.75 ± 0.08 1.51 ± 0.20 ND ND ND ND 0.043 ± 0.006
hPrp8
a,c 0.37 ± 0.03 0.040 ± 0.003 ND ND ND ND 0.030 ± 0.002
NA, not applicable. Diffusion coefficients Df FRAP DRB were calculated from fits of the FRAP curves measured in the nucleoplasm and the splicing factor compartments 
in DRB-treated cells. Dissociation rates koff nt were derived from fits of the FRAP curves measured in the nucleoplasm and splicing factor compartments of nontreated 
cells. Kinetic parameters koff nucl isog and Df nucl isog were derived from fits of the FRAP curves measured in the nucleoplasm of isoginkgetin-treated cells. Dissociation rates   
koff E3 gene loci were calculated from fits of the FRAP curves measured at the transcription site of the E3 transgene in doxycycline-treated E3 U2-OS cells. The mean ± 
SEM is shown.
aBAC stable cell line.
bHeLa cells.
cE3 U2-OS cells.81 Spliceosome assembly in the cell nucleus • Huranová et al.
formation. To analyze the integrity of tri-snRNP complexes after 
splicing inhibition, U4/U6 snRNP– and U5 snRNP–specific pro-
teins were immunoprecipitated from isoginkgetin-treated cells, 
and coprecipitated snRNAs were analyzed (Fig. 4 G). After splic-
ing inhibition, we detected a decrease in the level of U4 and U6 
snRNAs associated with hPrp4 and hPrp8 proteins, confirming 
that di- and tri-snRNP formation is reduced. Interestingly, we no-
ticed an increase in the association of U1 snRNA with U5 snRNP, 
possibly  reflecting  the  observed  immobilized  fraction  of   
U5 snRNP in FRAP measurements after splicing inhibition. Collec-
tively, the immunoprecipitation data demonstrated that active 
splicing is necessary for di- and tri-snRNP integrity.
Collectively, our data showed that snRNP–pre-mRNA inter-
actions can be measured by FRAP. In addition, the snRNPs   
that form the core active spliceosomal complex exhibited signifi-
cantly longer interaction times (15–30 s), whereas U1 and U4/U6 
snRNP proteins only transiently associated with pre-mRNA. This 
result is consistent with their role during intron definition 
(U1 snRNP) and spliceosome formation (U4/U6 snRNP).
Splicing inhibition disrupts  
snRNP complexes
The different dynamic behavior of U4/U6 and U5 snRNP proteins 
in the presence of isoginkgetin implies impaired tri-snRNP   
Figure 4.  The prolonged interaction of U1 and U2 snRNPs with pre-mRNA after splicing inhibition. (A) After isoginkgetin treatment, GFP-tagged snRNP 
proteins relocalized to enlarged splicing factor compartments. FRAP measurements were performed in the nucleoplasm, as depicted by circles. Bar,   
5 µm. (B) Splicing inhibition increased the immobile fractions and reduced the mobility of U1-70K and U2A (Table II). The mean of 10–12 measurements 
is shown. (C) Coimmunoprecipitation of U1 snRNA with U2A-GFP after isoginkgetin (isog) treatment. (D) Splicing inhibition had minimal impact on U4/U6 
snRNP mobility (Table II). (E) Splicing inhibition resulted in increased U5 snRNP mobility that can be described by a pure diffusion model. A portion of U5 
snRNPs was bound in an immobile fraction. (F) Schematic representation of snRNP interaction times with pre-mRNA after splicing inhibition. (G) Coimmuno-
precipitation of snRNAs from hPrp4-GFP and hPrp8-GFP cell lines with anti-GFP antibodies before and after isoginkgetin treatment. Splicing inhibition 
impairs U4/U6 di-snRNP and U4/U6•U5 tri-snRNP formation as shown by the reduced coprecipitation of U4 and U6 snRNAs with hPrp4 and hPrp8 
proteins. The vertical black line indicates that intervening lanes have been spliced out. (H) The efficiency of GFP-tagged protein immunoprecipitation was 
verified by Western blot analysis. NC, negative control.JCB • VOLUME 191 • NUMBER 1 • 2010   82
similar to nucleoplasmic spots, the binding rates of snRNPs dif-
fered at the artificial gene locus, again indicating the independent 
interaction of spliceosomal snRNPs with E3 pre-mRNAs.
Discussion
We have successfully measured the dynamics of snRNP com-
plexes in the cell nucleus and calculated the parameters that de-
scribe their movement throughout the nucleoplasm and their 
interactions with pre-mRNA. By using two different techniques, 
FRAP and FCS, we show that the diffusion of U1, U2, U4/U6, 
and U5 snRNPs is comparable and that their diffusion rates 
range between 0.2 and 0.8 µm
2s
1. Importantly, similar values 
were determined from both techniques and in two different cell 
lines. Our data are consistent with the diffusion rate of U1-70K 
in plants (Df = 0.7 µm
2s
1; Ali et al., 2008) and humans (Df = 
0.5 µm
2s
1; (Grünwald et al., 2006) and the common snRNP 
protein, SmE, in human cells (Df = 0.8 µm
2s
1; Rino et al., 
2007). snRNP movement is slower than the movement of non-
snRNP splicing factors U2AF35/65, SF1, or SC35 (Df = 1.19–
1.40 µm
2s
1; Rino et al., 2007). As diffusion efficiency of 
nuclear factors is largely determined by transient interactions 
(Phair and Misteli, 2001), these data indicate that snRNPs en-
counter extensive interactions within the nuclear environment.
Surprisingly, in all cases, we observed a pool of proteins 
that were apparently not incorporated into snRNP complexes 
and diffused rapidly throughout the nucleoplasm. Similarly, two 
fractions were identified for U1 snRNP, a slower fraction with 
Differential interaction of snRNPs  
with E3 pre-mRNA
Our results reveal the dynamics of snRNPs in the nucleoplasm and 
are a mean representation of snRNP behavior over numerous gene 
loci. To analyze snRNP dynamics at a specific gene locus, we used 
the inducible E3 U2-OS Tet-On cell system (Fig. 5 A; Shav-Tal   
et al., 2004; Darzacq et al., 2006) that either stably expressed from 
BACs GFP-tagged U1-70K (U1 snRNP) or hPrp8 (U5 snRNP) or 
transiently expressed GFP-tagged U2B (U2 snRNP) or hPrp4 
(U4/U6 snRNP). Initially, we determined by FRAP that the diffu-
sion coefficients and binding constants of individual snRNPs in   
the nucleoplasm of U2-OS cells are similar to that of HeLa cells   
(Table II). Doxycycline treatment of U2-OS cells resulted in the 
expression of E3 gene (Fig. 5 B), as visualized in situ via its inter-
action with the MS2-mRED protein (Fig. 5 C). After induction 
with doxycycline, snRNP-specific proteins localized to the site of 
active transgene transcription (Fig. 5 C). For quantification of   
snRNP interaction in the E3 gene loci, we used the radial binding 
model accounting for boundary effects in the cluster of binding 
sites (Eq. 4; Sprague et al., 2006). FRAP measurements performed 
at the site of transgene transcription revealed a surprising reduction 
in koff values. The greatest reductions detected were U1 snRNP 
(17 fold) and U4/U6 snRNP (35 fold). koff values for   
U2 snRNP and U5 snRNP dropped only partially (Fig. 5 D and   
Table II). These data illustrate that the dynamics of snRNPs differ 
at a specific gene compared with the mean values measured in the 
nucleoplasm. This might reflect either massive E3 gene transcrip-
tion or specific splicing kinetics for E3 pre-mRNA. However,   
Figure 5.  snRNP interaction with E3 pre-mRNA. (A) Schematic representation of the E3 gene stably integrated into the genome of the U2-OS Tet-On cell 
line. Expression of the E3 transgene is driven by a minimal cytomegalovirus promoter (Pmin) under the control of the tetracycline response element (TRE) 
and is induced by the presence of doxycycline (DOX) by the reverse transactivator, rtTA. The transgene transcript contains 18× MS2-binding sites, and the 
encoded protein (human -globin) is fused to CFP-SKL. (B) E3 transgene expression before and after induction. (C) Doxycycline-treated E3 cells expressing 
different GFP-tagged snRNP proteins (top) and MS2-mRED protein (bottom). Note the localization of snRNP proteins at the site of active transgene transcrip-
tion, as depicted by MS2-mRED accumulation (arrows). Bar, 5 µm. (D) FRAP analysis of snRNP dynamics at the active transcription site of the E3 transgene 
(Table II). A mean of 10–12 measurements is shown.83 Spliceosome assembly in the cell nucleus • Huranová et al.
production. Thus, snRNPs could be reused at this site and be 
involved  in  several  splicing  reactions  without  leaving  the 
transcription loci, resulting in the observation of a prolonged 
residence time.
Our comprehensive analysis of snRNP dynamics in the cell 
nucleus reveals that snRNPs roam throughout the cell nucleus and 
continuously scan their environment via numerous transient inter-
actions. Once snRNPs encounter a pre-mRNA substrate, they   
assemble the active splicing complex, accomplish the splicing   
reaction, and dissociate to be recycled for another round of splic-
ing. Similar to other active multicomponent complexes (e.g., trans-
lation or transcription initiation complexes), the active spliceosome 
is formed from preassembled snRNPs only at the time and place of 
its need, allowing the assembly process to be regulated.
Materials and methods
Protein cloning and tagging
EST clones of human U1-70K and U2B were obtained from imaGenes. ORFs 
were amplified by the Expand long template PCR system and cloned into 
pEGFP-N1 (Takara Bio Inc.) using BamHI and EcoRI or BglI and EcoRI restric-
tion sites. The truncated mutant U1-70K1–197 protein was generated by   
deleting (using KpnI and BamHI restriction sites) the first 1–197 aa from the 
full-length human U1-70K cDNA and cloned into pEGFP-C1 (Takara Bio Inc.). 
The construct hPrp4 GFP-C2 was obtained from D.S. Horowitz (Cold Spring 
Harbor Laboratory, Cold Spring Harbor, NY). The construct MS2-mRED was 
generated upon subcloning the MS2 sequence from pMS2-EYFP-N1 (Huranová 
et al., 2009b) into pDsRed-Monomer-N1 (Takara Bio Inc.) using the XhoI and 
BamHI restriction sites.
BAC tagging
BACs harboring the genes encoding human spliceosomal proteins (U1-70K, 
U2A, hPrp4, hPrp31, and hPrp8) and the mouse homologue of the splice-
osomal protein (Snu114) were obtained from the BACPAC Resources Center. 
The EGFP-IRES-Neo cassette (LAP) was inserted into the BAC by recombina-
tion as described previously (Zhang et al., 1998; Poser et al., 2008). In brief, 
the C-terminal tagging cassette (LAP) was PCR amplified with gene-specific 
primers carrying 50 nt of homology to the targeting sequence. Next, purified 
PCR product was inserted at the C terminus of the gene of interest using   
homologous recombination. Correct insertion of the tag was verified by PCR.
Cell cultures and treatments
HeLa cells were cultured in high-glucose DME supplemented with 10% fetal 
calf serum, penicillin, and streptomycin (Invitrogen). Stable cell lines express-
ing the recombinant BACs were generated by transfection of HeLa cells with 
Effectene and selected with geneticin. The E3 U2-OS Tet-On cell line was gen-
erated by cointegrating the E3 gene (Shav-Tal et al., 2004) lacO repeats and 
puromycin resistance in U2-OS Tet-On cells. BAC E3 U2-OS cell lines were 
generated by transfection of E3 U2-OS cell lines with BACs and selecting with 
hygromycin. E3 cells were cultured in low-glucose DME containing 10% fetal 
calf serum, penicillin, and streptomycin. Transcription of the transgene in E3 
U2-OS cells was induced using 6 µg/ml doxycycline. Doxycycline was added 
6–10 h after transfection, and cells were assayed 12–16 h later. For transcrip-
tional inhibition, cells were treated with 50 µM DRB (Sigma-Aldrich) or 50 µM 
-amanitin (Sigma-Aldrich) for 5 h. For splicing inhibition, cells were treated 
overnight with 100 µM isoginkgetin (LGC Standards).
Plasmids and siRNA transfection
Transient transfections of HeLa and E3 U2-OS cell lines with plasmids were 
performed using Fugene HD (Roche) according to the manufacturer’s proto-
col. Preannealed siRNA duplexes were obtained from Applied Biosystems: 
hSnu114  3  untranslated  region,  5-GCUGCUGUUGCCAUCUUGATT-3. 
The negative control 1 siRNA from Applied Biosystems was used as a nega-
tive control. siRNA transfections were performed using Oligofectamine (Invit-
rogen) according to manufacturer’s protocol. Cells were incubated for 48–72 h 
before further analysis.
Proliferation assay after siRNA transfection
Cells were stained with 1 µM far-red fluorescent tracer DDAO-SE (Invitro-
gen) for 15 min at room temperature, plated, and, 24 h later, transfected 
with the appropriate siRNA. DDAO-SE intensity was measured at the time 
Df = 0.5 µm
2s
1 and a faster one with Df = 8.2 µm
2s
1 (Grünwald 
et al., 2006). In the case of the exon junction complex, free proteins 
were also detected (Schmidt et al., 2009). Together, these observa-
tions suggest that a fraction of unbound proteins is a common fea-
ture of proteins associated with multicomponent complexes.
The mathematical model used for FRAP data analysis not 
only enabled the estimation of diffusion rates but also allowed 
the approximation of snRNP-binding properties to nuclear com-
ponents. Treatment of cells with transcriptional and splicing in-
hibitors demonstrated that in the nucleoplasm, the dominant 
interaction partner of snRNPs is pre-mRNA. U1 and U4/U6 snRNP 
components exhibit fast dynamic exchange with a residence time 
of <1 s, whereas U2 and U5 snRNP proteins interact longer   
with pre-mRNA with a residence time of 15–30 s (Fig. 3 F).   
If the spliceosome interacts with pre-mRNA in a big complex 
that contains all five snRNPs, individual snRNPs should have a 
similar residence time. Therefore, our results are consistent with 
the step-wise assembly model that proposes the transient inter-
action of U1 and U4/U6 snRNP proteins with pre-mRNA during 
the spliceosome formation and the longer association of U2 and   
U5 snRNP proteins that constitute the activated spliceosome (for re-
views see Rino and Carmo-Fonseca, 2009; Wahl et al., 2009).
The  residence  times  of  the  core  splicing  components   
(U2 and U5 snRNPs) can provide us with an estimate of the mean 
splicing rate in living cells. Our results suggest that splicing is 
accomplished within 30 s. Compared with previous studies that 
inferred that the splicing rate from intron removal after transcrip-
tion induction or repression is between 0.5 and 10 min, our value 
is much faster (Audibert et al., 2002; Singh and Padgett, 2009). 
However, the rate of intron removal depends on many factors, 
including the rate of RNA synthesis and the rate of splice site 
recognition. Our results provide the first in vivo splicing rate es-
timate in a mammalian system that is independent of the speed 
of RNA synthesis and involves only the rate of splicing and   
assembly/disassembly of the spliceosome. We cannot absolutely 
rule out the possibility that GFP influences incorporation and 
behavior of tagged proteins in the spliceosome. However, GFP-
tagged proteins are properly incorporated into snRNPs, GFP-
Snu114 is able to partially rescue the proliferation phenotype, 
and two different proteins from the same snRNP complex ex-
hibit identical kinetics. In addition, our results correlate well 
with the analysis of Miller spreads from Drosophila melano-
gaster embryos and ChIP data from yeast, which both suggest 
that splicing is accomplished within 1 min after spliceosome 
formation (Beyer and Osheim, 1988; Wetterberg et al., 2001; 
Görnemann et al., 2005). The immobile fractions of U2 and   
U5 snRNPs (10%) indicate that the splicing of some genes can 
take significantly longer than 30 s and might reflect delayed or 
regulated posttranscriptional splicing (LeMaire and Thummel, 
1990; Wetterberg et al., 1996). Interestingly, the interaction of 
snRNPs with -globin–based E3 pre-mRNA differs from the 
mean nucleoplasmic values. It was reported previously that the 
splicing rates of different introns vary significantly (Audibert et al., 
2002). Therefore, it is plausible that the interaction of individual 
snRNPs and spliceosome assembly at one or both -globin introns 
diverge from the mean. In addition, the accumulation of snRNPs 
at the artificial gene loci indicates a high rate of pre-mRNA   JCB • VOLUME 191 • NUMBER 1 • 2010   84
level and temperature. The FCS system contained a pulsed diode laser 
(LDH-P-C-470; 470 nm; PicoQuant) providing 80-ps pulses at up to a 40-MHz 
repetition rate, a proper filter set (cleanup filter Z470/20, dichroic mirror 
z490rdc, and bandpass filter HQ515/50; Chroma Technology Corp.), a 
water immersion objective (60× NA 1.2; Olympus), 50-µm pinhole, and a 
single-photon avalanche diode detector. Data were acquired in TTTR mode 
using SymphoTime200 software (PicoQuant), and F(L)CS data analysis 
was performed using home-built routines (DevC++ [Bloodshed Software] 
and OriginPro80 [OriginLab Corporation]). First, standard fluorescence in-
tensity images of the cells using low laser power (1 µW at the back aper-
ture of the objective) were acquired to properly localize the nucleus in all 
three dimensions. Subsequently, a set of point measurements (120 s each) 
with optimized power (3.6 µW at the back aperture of the objective, com-
promise between brightness and minimal photobleaching) were performed 
at selected locations within the nucleoplasm and the splicing factor com-
partments. FCS analysis of each point measurement consisted of (a) filter-
ing out uncorrelated noise contributions (detector after pulsing and dark 
noise; Humpolícková et al., 2008), (b) estimation of SD for each lag time 
by splitting the measurement into 10 pieces (Benda et al., 2003), and (c) 
weighted nonlinear least square fit (Levenberg-Marquardt routine) by a theo-
retical model. For fitting the autocorrelation curves, we applied the pure 
diffusion model with one or two components using the standard equation 
for free three-dimensional translational diffusion:
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i is the experimental brightness of i-th species, G() is the autocorrelation 
function, N stands for the number of particles in the effective volume Veff, SP 
is a structure parameter, a constant for the given experimental setup, de-
fined as the ratio of long, and short axis of the ellipsoidal detection volume 
SP = z0/0, D is diffusion time. The size of the effective volume is Veff = 

3/20
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For fitting the autocorrelation curves of EGFP, we applied the one-
component three-dimensional anomalous diffusion model:
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where  is the anomaly exponent ( = 1 for normal diffusion,  < 1 for sub-
diffusion [usually encountered in cells], and  > 1 for superdiffusion).
FRAP acquisition, data processing, and analysis
Cells were plated on glass-bottomed Petri dishes and, after 20–24 h, were 
transfected with the appropriate DNA constructs. The cells were imaged 
22–24 h after transfection and/or drug treatment by using the SP5 con-
focal microscope equipped with an oil immersion objective (HCX Plan- 
Apochromat  63×  NA  1.40-0.6  oil,  Lbd  Blue  CS)  and  an  environmental 
chamber controlling CO2 level and temperature. Data acquisition was per-
formed using a 512 × 512–pixel format at a 1,400-Hz scan speed and 1.6 
Airy pinhole in 16-bit resolution. Bleaching (0.37 s) was performed with a 
circular spot 1.5 µm in diameter using the 488-nm line of a 100-mW argon 
laser operating at 100% laser power. Fluorescent recovery was monitored 
at low laser intensity (5–10% of a 100-mW laser) at 0.37-s intervals at the 
beginning of the recovery and at 0.37–1-s intervals when reaching the pla-
teau of recovery. 10–15 separate FRAP measurements were performed for 
each experiment. FRAP curves were double normalized to whole cell fluor-
escence loss during acquisition and background. Normalized FRAP curves 
were fitted either with the pure diffusion model or full model equations, and 
the quality of the fit is illustrated with the R
2 value shown in the figures.
To fit the FRAP curves with the pure diffusion model, we used the fol-
lowing equation derived from Sprague et al. (2004):
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of transfection and 50 h after transfection. Unstained cells were measured 
as a negative control. Dilution of DDAO-SE signal caused by an increasing 
number of cells was measured using a flow cytometer (633-nm laser; LSRII; 
BD) and analyzed with FlowJo software (Tree Star, Inc.).
Antibodies
Goat -GFP polyclonal antibodies (raised against bacterially expressed full-
length EGFP) used for immunoprecipitation were a gift from D. Drechsel 
(Max Planck Institute for Molecular Cell Biology and Genetics, Dresden, Ger-
many). The Y12 antibody was produced in the Institute of Molecular Genetics 
(Academy of Sciences of the Czech Republic, Prague, Czech Republic) anti-
body facility using a hybridoma cell line. The mouse monoclonal -BrdU anti-
body was purchased from Sigma-Aldrich. The following antibodies were used 
for  Western  blot  analysis:  the  rabbit  polyclonal  antibody  -hSnu114   
(U5-116K; gift from R. Lührmann, Max Planck Institute for Biophysical Chemis-
try, Göttingen, Germany), the mouse monoclonal -tubulin antibody (gift from   
P. Dráber, Institute of Molecular Genetics), the mouse monoclonal -GFP anti-
body (Santa Cruz Biotechnology, Inc.), and goat anti–mouse and anti–rabbit 
antibodies conjugated with horseradish peroxidase (The Jackson Laboratory).
snRNP immunoprecipitation and Western blot analysis
HeLa and HeLa BAC cell lines were grown on a 15-cm Petri dish for 28 h. 
Cells were treated with the aforementioned drugs before harvesting. Immuno-
precipitation  was  performed  as  described  previously  (Huranová  et  al., 
2009a) using the mouse -Sm antibody (Y12) or goat -GFP antibodies. RNA 
was extracted using phenol/chloroform, resolved on a 7-M urea-denaturing 
polyacrylamide gel, and silver stained. Alternatively, after immunoprecipita-
tion, a fraction of Sepharose beads was resuspended in SDS-PAGE sample 
buffer, and proteins were resolved on 8% polyacrylamide gel. The immuno-
precipitated proteins were detected with the -GFP mouse monoclonal anti-
body and secondary anti–mouse antibodies conjugated with peroxidase 
using SuperSignal West Pico (Thermo Fisher Scientific).
RT-PCR and quantitative PCR
Total RNA was isolated 24 h after treatment using TRIZOL reagent (Invitro-
gen). cDNA was synthesized using gene-specific reverse primers and re-
verse transcription SuperScript III (Invitrogen). Taq polymerase was used   
to amplify cDNA. Controls without RT reaction were performed to verify   
no residual DNA contamination. Quantitative PCR was performed as de-
scribed previously (Listerman et al., 2006), and the ratio of pre-mRNA to 
mRNA was calculated according to Risoginkgetin = 2
(Ctpre-mRNA  CtmRNA), normal-
ized to DMSO-treated cells (Rn = Risoginkgetin/RDMSO), and plotted.
The following primers were used for RT-PCR and quantitative PCR: 
18S forward, 5-TTGTTGGTTTTCGGAACTGAG-3; 18S reverse, 5-GCAA-
ATGCTTCGGCTCTGGTC-3; HBB exon 1 intron 1 forward, 5-CCTGGG-
CAGGTTGGTATCAAG-3; HBB intron 2 exon 3 reverse, 5-GCCCAGGAG-
CTGTGGGAGGAA-3; HBB exon 1 exon 2 forward, 5`-CCTGGGCAGGCT-
GCTGGTGGT-3; HBB exon 2 exon 3 reverse, 5-GCCCAGGAGCCTGA-
AGTTCTC-3; LDHA intron 14 exon 15 forward, 5-CCTTTCAACTCTCTTTT-
GGCAACC-3; LDHA intron 14 exon 15 reverse, 5-AATCTTATTCTGGGG-
GGTCTGTTC-3; LDHA exon 3 exon 5 forward, 5-AGAACACCAAAGATTG-
TCTCTGGC-3; LDHA exon 3 exon 5 reverse, 5-TTTCCCCCATTAGGTA-
ACGG-3; CACNA1G exon 13 intron 13 forward, 5-CTTCGGCAAC-
TACGTGCTCT-3; CACNA1G exon 13 intron 13 reverse, 5-AATTGGAAG-
TGGGACTGCTG-3; CACNA1G exon 13 forward, 5-CCAGGAGGACT-
GGAACAAAG-3; CACNA1G exon 13 reverse, 5-AGAGCACGTAGTTGC-
CGAAG-3; FN1 intron 14 exon 15 forward, 5-AAAATGATGTTGGC-
GACGAG-3; FN1 intron 14 exon 15 reverse, 5-CGTCTCTCCTGTCACG-
GTGT-3; FN1 exon 24 forward, 5-GGAAGAAGTGGTCCATGCTG-3; 
and FN1 exon 24 reverse, 5-GGGACACTTTCCTTGTCATCC-3.
Image acquisition and processing
Images were acquired using a confocal microscope (SP5; Leica) equipped 
with an oil immersion objective (HCX Plan-Apochromat 63× NA 1.40-0.6 
oil, Lbd Blue CS), with 512 × 512–pixel format at 400-Hz scan speed and 
1.6 Airy pinhole in 16-bit resolution. Frame averaging 6× was used in   
Fig. 1 A. Line averaging was used in following figures: 4× in Fig. 2 and 8× in 
Fig. 5 C. Figs. 3 A and 4 A are the first frames of the FRAP experiments, 
acquired at 1,400-Hz scan speed with no line averaging. All images were 
adjusted for brightness and contrast, and the raw images of Figs. 1 A,   
2 (A–C), 3 A, 4 A, and 5 C are available on the JCB DataViewer.
FCS acquisition, data processing, and analysis
Cells plated on glass-bottomed Petri dishes (MatTek) were imaged using an 
inverted epifluorescence scanning confocal microscope (MicroTime 200; 
PicoQuant)  equipped  with  an  environmental  chamber  controlling  CO2 85 Spliceosome assembly in the cell nucleus • Huranová et al.
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The actual recovery model is obtained by numerical inversion of 
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